Abstract:OBJECTIVE:To investigate the therapeutical effect of adenovirus-mediated vascular endothelial growth factor (VEGF)165 gene transplantation in treatment of hypoxic-ischemic brain damage.METHODS:Recombinant vector of adenovirus-mediated VEGF165 gene (Ad-VEGF) was constructed by bacterial homologous recombination technology. Sixty 7-day-old Sprague-Dawley rats were randomly divided into 3 equal groups: hypoxic-ischemic brain damage (HIBD) group undergoing ligation of the left common carotid artery and inhalation of 8% oxygen for 2 hours, Ad-VEGF group undergoing injection of Ad-VEGF into the left sensorimotor cortex with the help of stereo-positioner 3 days after hypoxia-ischemia (HI), and sham operation group. Seven days after transplantation, 5 rats from each group were killed with their left brains taken out. The VEGF protein expression was detected by immunohistochemistry, and the neuron apoptosis was detected by terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nickel end labeling (TUNEL). Since the age of 28 days T-maze foraging test was conducted. At the age of 34 days, sensorimotor tests were performed. After the behavioral tests all the rats were killed. The number of neurons in the CA1 region of the hippocampus and cerebral cortex was detected by Nissl's staining.RESULTS:Immunohistochemistry showed that the density levels of VEGF positive cells in cerebral cortex and hippocampus of the Ad-VEGF group were (68.09 +/- 3.37) and (68.37 +/- 3.17) respectively, both significantly higher than those of the HIBD group [(24.65 +/- 3.14) and (25.14 +/- 1.86) respectively, both P < 0.05]. TUNEL showed that the number of apoptotic neurons of the Ad-VEGF group was (151.4 +/- 21.7), significantly lower than that of the HIBD group [(264.4 +/- 16.3), P < 0.05]. Behavioral tests showed the percentages of accuracy on day 4 of the Ad-VEGF and sham operation groups were both significantly higher than that of the HIBD group (both P < 0.01). Nissl's staining showed that the numbers of neurons per unit area in the hippocampal CA1 area and cortex of the Ad-VEGF group were (70.6 +/- 2.3) and (95.1 +/- 2.8) respectively, both significantly higher than those of the HI group [(55.3 +/- 2.1) and (70.1 +/- 2.7) respectively, both P < 0.05].CONCLUSION:Adenovirus vector-mediated VEGF gene therapy increases the VEGF protein expression, decreases neuron apoptosis, improves the long-term behavioral function after brain damage, and reduces hypoxic ischemic brain injury, thus possessing neuroprotective effects.

Experimental Research on the Effect of VEGF on Angiogenesis in Focal Cerebral Ischemia

Protective effects of basic fibroblast growth factor against global cerebral ischemia/reperfuslon injury in rabbits

Intranasal Administration of VEGF with Effect on Angiogenesis in Infarction Boundary Zones in Rats with Cerebral Ischemia

Neuroprotective Effect of VEGF/VEGFR in Cerebral Ischemia Reperfusion Injury

Retroviral vector mediated vascular endothelial growth factor gene therapy for experimental rabbits with cerebral ischemia

Study of Molecule Mechanism of Cerebral Ischemia/reperfusion Injury with VEGF

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

The dose-effectiveness of intranasal VEGF in focal cerebral ischemia/reperfusion injury of rats

Intraventricular Vascular Endothelial Growth Factor Antibody Increases Infarct Volume Following Transient Cerebral Ischemia.

NO upgrades expression of VEGF protein and mRNA in local ischemic brain tissues of rabbits

VEGF Promotes Angiogenesis and Functional Recovery in Stroke Rats.

Intraventricular Injection of Liposome-Mediated VEGF Plasmids Enhances Brain Repair Following Ischemia-Reperfusion Injury

[Vasoactive Intestinal Peptide Enhances Angiogenesis after Focal Cerebral Ischemia].

The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.

Effects of Angelica Sinensis on the Expression of Vascular Endothelial Growth Factor after the Brain Ischemia-Reperfusion Injury in Rats

VEGF Ameliorates Cognitive Impairment in In Vivo and In Vitro Ischemia via Improving Neuronal Viability and Function

[Adenovirus-Mediated Vascular Endothelial Growth Factor165 Gene Therapy in Treatment of Hypoxic-Ischemic Brain Damage: Experiment with Rats].

Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion

VEGF Alleviates Cerebral Ischemia/reperfusion Injury and the Results in Expression of Caspase-3 in Rabbits

Adeno-associated Viral Vector-Mediated Hypoxia-Regulated VEGF Gene Transfer Promotes Angiogenesis Following Focal Cerebral Ischemia in Mice

Vasoactive intestinal peptide in rats with focal cerebral ischemia enhances angiogenesis.